ArticleNPJ digital medicine2026
An ultrasound foundation model for the stratification of vision impairment and eye cancer risk.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The prevalence of vision disorders and eye cancer risk, driven by global population aging, necessitates precise ophthalmological disease screening, yet standardized and robust approaches for risk stratification remain absent. Here, we present SonoEye, a vision-language ultrasound foundation model for eye disease risk stratification, pre-trained on 215,356 image-text pairs from 70,452 patients using contrastive learning and fine-tuned with consensus-confirmed patient-level labels. The model achieves 98.3% screening sensitivity and a mean accuracy of 96.3% in differentiating 18 diseases. We established the Eye Reporting and Data System (Eye-RADS), a 4-tier risk stratification framework (normal, low-vision risk, high-vision risk, and tumor risk), demonstrating excellent Cohen's kappa agreement across internal (0.808) and external (0.677-0.685) test cohorts. Notably, incorporating age significantly improved Eye-RADS performance in elderly but not younger populations, indicating age-related features in eye care. Through image-text alignment, SonoEye generates structured clinical reports with interpretable attention-based visualizations, advancing automated vision risk stratification, particularly for aging populations in resource-limited settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.